Incidental Mutation 'R2890:Phex'
ID |
260084 |
Institutional Source |
Beutler Lab
|
Gene Symbol |
Phex
|
Ensembl Gene |
ENSMUSG00000057457 |
Gene Name |
phosphate regulating endopeptidase homolog, X-linked |
Synonyms |
HPDR1 |
MMRRC Submission |
040478-MU
|
Accession Numbers |
|
Essential gene? |
Possibly non essential
(E-score: 0.474)
|
Stock # |
R2890 (G1)
|
Quality Score |
222 |
Status
|
Not validated
|
Chromosome |
X |
Chromosomal Location |
155945071-156198282 bp(-) (GRCm39) |
Type of Mutation |
missense |
DNA Base Change (assembly) |
T to C
at 156093954 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
Isoleucine to Valine
at position 439
(I439V)
|
Ref Sequence |
ENSEMBL: ENSMUSP00000122953
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000079945]
[ENSMUST00000138396]
|
AlphaFold |
P70669 |
Predicted Effect |
probably benign
Transcript: ENSMUST00000079945
AA Change: I439V
PolyPhen 2
Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
|
SMART Domains |
Protein: ENSMUSP00000078863 Gene: ENSMUSG00000057457 AA Change: I439V
Domain | Start | End | E-Value | Type |
transmembrane domain
|
21 |
40 |
N/A |
INTRINSIC |
Pfam:Peptidase_M13_N
|
77 |
479 |
6.1e-95 |
PFAM |
Pfam:Peptidase_M13
|
538 |
748 |
3.5e-70 |
PFAM |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000138396
AA Change: I439V
PolyPhen 2
Score 0.003 (Sensitivity: 0.98; Specificity: 0.44)
|
SMART Domains |
Protein: ENSMUSP00000122953 Gene: ENSMUSG00000057457 AA Change: I439V
Domain | Start | End | E-Value | Type |
transmembrane domain
|
21 |
40 |
N/A |
INTRINSIC |
Pfam:Peptidase_M13_N
|
77 |
479 |
4.2e-116 |
PFAM |
|
Meta Mutation Damage Score |
0.0898 |
Coding Region Coverage |
- 1x: 99.3%
- 3x: 98.6%
- 10x: 97.3%
- 20x: 95.1%
|
Validation Efficiency |
|
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a transmembrane endopeptidase that belongs to the type II integral membrane zinc-dependent endopeptidase family. The protein is thought to be involved in bone and dentin mineralization and renal phosphate reabsorption. Mutations in this gene cause X-linked hypophosphatemic rickets. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013] PHENOTYPE: Males hemizygous for a null mutation exhibit reduced body size, shortened hindlimbs and tail, osteomalacia, and markedly reduced plasma phosphate levels due to impaired kidney reabsorption. Female heterozygotes exhibit milder symptoms. [provided by MGI curators]
|
Allele List at MGI |
|
Other mutations in this stock |
Total: 30 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
4930480E11Rik |
A |
T |
X: 77,414,288 (GRCm39) |
I338F |
probably damaging |
Het |
A1cf |
A |
G |
19: 31,895,417 (GRCm39) |
I167V |
probably benign |
Het |
Adamts20 |
C |
T |
15: 94,228,459 (GRCm39) |
R996H |
probably benign |
Het |
Amdhd1 |
T |
C |
10: 93,363,126 (GRCm39) |
K321E |
probably benign |
Het |
Baz1a |
T |
C |
12: 54,945,302 (GRCm39) |
H1351R |
probably benign |
Het |
Cep63 |
T |
C |
9: 102,496,026 (GRCm39) |
D127G |
probably damaging |
Het |
Chrm5 |
T |
C |
2: 112,310,048 (GRCm39) |
Y356C |
probably benign |
Het |
Dock4 |
A |
T |
12: 40,673,800 (GRCm39) |
|
probably null |
Het |
Dync1h1 |
T |
C |
12: 110,583,325 (GRCm39) |
L474P |
probably damaging |
Het |
Fzd7 |
C |
T |
1: 59,523,593 (GRCm39) |
A492V |
probably benign |
Het |
Greb1 |
A |
G |
12: 16,754,479 (GRCm39) |
L876P |
probably damaging |
Het |
Grik4 |
T |
C |
9: 42,582,515 (GRCm39) |
T144A |
probably damaging |
Het |
Gusb |
T |
C |
5: 130,029,343 (GRCm39) |
H146R |
probably damaging |
Het |
Hspg2 |
T |
C |
4: 137,276,885 (GRCm39) |
V2835A |
probably damaging |
Het |
Lamp1 |
T |
A |
8: 13,223,891 (GRCm39) |
L341H |
probably damaging |
Het |
Lcn10 |
T |
C |
2: 25,573,642 (GRCm39) |
L73P |
probably damaging |
Het |
Nostrin |
A |
G |
2: 69,011,249 (GRCm39) |
T347A |
probably benign |
Het |
Or4k41 |
A |
T |
2: 111,279,634 (GRCm39) |
I50F |
probably benign |
Het |
Pcdhb9 |
G |
A |
18: 37,536,379 (GRCm39) |
C791Y |
probably benign |
Het |
Rbsn |
C |
T |
6: 92,184,104 (GRCm39) |
V70M |
possibly damaging |
Het |
Slc25a1 |
A |
T |
16: 17,743,963 (GRCm39) |
L251Q |
probably damaging |
Het |
Slc35a5 |
A |
G |
16: 44,971,923 (GRCm39) |
C114R |
probably damaging |
Het |
Srek1ip1 |
A |
T |
13: 104,970,758 (GRCm39) |
I70L |
probably benign |
Het |
Taf4b |
T |
C |
18: 14,937,849 (GRCm39) |
S278P |
probably damaging |
Het |
Ttn |
T |
C |
2: 76,726,498 (GRCm39) |
|
probably benign |
Het |
Vmn2r13 |
T |
C |
5: 109,339,840 (GRCm39) |
D45G |
possibly damaging |
Het |
Vmn2r66 |
C |
T |
7: 84,661,027 (GRCm39) |
|
probably null |
Het |
Ylpm1 |
G |
T |
12: 85,076,587 (GRCm39) |
R646L |
probably damaging |
Het |
Zfp51 |
C |
G |
17: 21,684,118 (GRCm39) |
C244W |
probably damaging |
Het |
Zfp619 |
C |
A |
7: 39,184,393 (GRCm39) |
T141K |
probably benign |
Het |
|
Other mutations in Phex |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL00777:Phex
|
APN |
X |
155,960,528 (GRCm39) |
missense |
probably damaging |
1.00 |
IGL02176:Phex
|
APN |
X |
156,051,489 (GRCm39) |
missense |
probably damaging |
1.00 |
IGL02501:Phex
|
APN |
X |
155,969,271 (GRCm39) |
missense |
probably damaging |
1.00 |
IGL02502:Phex
|
APN |
X |
155,966,823 (GRCm39) |
missense |
possibly damaging |
0.93 |
IGL03214:Phex
|
APN |
X |
155,960,500 (GRCm39) |
missense |
probably damaging |
0.99 |
IGL03218:Phex
|
APN |
X |
155,961,783 (GRCm39) |
missense |
probably damaging |
1.00 |
R0240:Phex
|
UTSW |
X |
155,969,214 (GRCm39) |
missense |
probably damaging |
1.00 |
R0240:Phex
|
UTSW |
X |
155,969,214 (GRCm39) |
missense |
probably damaging |
1.00 |
R0726:Phex
|
UTSW |
X |
156,155,557 (GRCm39) |
splice site |
probably benign |
|
R2888:Phex
|
UTSW |
X |
156,093,954 (GRCm39) |
missense |
probably benign |
0.00 |
R2889:Phex
|
UTSW |
X |
156,093,954 (GRCm39) |
missense |
probably benign |
0.00 |
Z1177:Phex
|
UTSW |
X |
156,192,960 (GRCm39) |
missense |
probably damaging |
1.00 |
|
Predicted Primers |
PCR Primer
(F):5'- CCTCTGGGGTCATTTGGAAAC -3'
(R):5'- GAACTTGTACTGTCACCACCTTG -3'
Sequencing Primer
(F):5'- CTTCCATCCAAAGAAGTCCT -3'
(R):5'- ACCACCTTGCATCATCTGTTTACAG -3'
|
Posted On |
2015-01-23 |